MindAhead

MindAhead is a digital tool for early detection of cognitive impairment and the first therapy app for people with mild cognitive impairment designed to prevent or slow the onset of dementia and improve patients' quality of life.

Our platform is specifically designed to enhance the quality of life, cognitive abilities, mental health, daily functioning, self-efficacy, and active lifestyle (cognitive, social, and physical) of adults with mild cognitive disorder (MCI) (ICD-10-GM code: F06.7), with a goal of preventing manifest dementia. We achieve this through an evidence-based treatment plan that combines behavioral activation and cognitive training, utilizing a user interface that is tailored to the cognitive state of patients with mild cognitive impairment for effective long-term treatment. Our approach incorporates the latest in artificial intelligence, utilizing machine learning and conversational AI to detect the early signs of mild cognitive impairment and engage users through our proprietary algorithm.

At our core, we envision a future where digital therapeutics for the elderly are readily available and utilized, tapping into the vast potential of our aging society. Our initial focus is on Alzheimer's disease, but as we establish a solid platform and obtain necessary certifications, we plan to expand our reach to other age-related diseases.

Our vision is to lead the charge in providing effective and accessible digital therapeutic solutions to benefit our aging population.